Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Heart Lung Transplant. 2012 Mar 28;31(6):601–610. doi: 10.1016/j.healun.2012.02.027

Figure 2. Sub-analysis of survival in patients with continuous flow devices based on the degree of liver dysfunction assessed by MELD-XI score at the time of VAD implantation.

Figure 2

Figure 2

12-month on-VAD survival based on MELD-XI scores shows significantly worse outcomes for patients with a score ≥17 compared to patients with scores <17 (a). Overall survival up to 5 year after VAD implantation based on MELD-XI scores demonstrate a significantly worse outcome for patients with a score ≥17 compared to patients with scores <17 (b).